Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201 - Wikidata - awgldk - TriplyDB

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201

http://www.wikidata.org/entity/Q34268509

about

The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation: a systematic review.Mobilizing plasmacytoid dendritic cells.Chemokine and lymph node homing receptor expression on pDC vary by graft source.Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning.Advances in understanding the pathogenesis of graft-versus-host disease.Granulocyte colony-stimulating factor-primed bone marrow: an excellent stem-cell source for transplantation in acute myelocytic leukemia and chronic myelocytic leukemia Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective.Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.Precision in donor selection: Identifying ideal stem-cell donors through their T cells.DLL4+ dendritic cells: Key regulators of Notch Signaling in effector T cell responses A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results.Immune roles of dendritic cells in stem cell transplantation.Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy.Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.A high migratory capacity of donor T-cells in response to the lymph node homing receptor CCR7 increases the incidence and severity of GvHD.Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.

P2860

Q26740251-11F38E5B-1A0D-403E-BB71-F24E131BFE33 Q26773952-AB72A9BB-16A5-48BF-81DA-802405B2DF19 Q30238975-FD0D8D4D-DFB4-4ACA-B77E-A94BDF743B6A Q33671986-391CFCEC-F0A6-45EA-9294-642105A90096 Q34931753-0B1E4AC9-7871-425A-84F3-2169B81E6AAA Q35584266-617927F5-143F-4242-83BB-08DDBC6D7323 Q35847466-C2B9CD2E-AE19-4DD8-9BCC-BF4337E31AD9 Q35971439-8814E7C5-37A3-445A-A74B-2EED12F034B2 Q36816176-9976DA58-ED53-4515-B689-5160B92BF499 Q38349208-A824BFB7-D07B-446A-9DE9-999A3EAF3363 Q38669334-D75D761C-5679-4694-B14B-382C3CCBE613 Q38920131-675B9521-9FF7-4C4F-8390-F18543AF86CD Q38957582-0467A102-8924-4263-ACC2-9F7890E59FDF Q41273685-7068308A-37B7-4CC7-B032-3069445D916B Q42106581-D2D222BC-7C6B-4708-96A8-802EC7C9F8EE Q47123396-A8204D64-0570-427B-8883-08B34479909C Q48192448-B4B7F9B6-FABF-43E0-BA14-D9561810859E Q50145136-19EF34C4-9B9F-4FAE-852A-8F02B26688F0 Q51099240-081CCE3F-8F98-4BE6-9C0B-D74B558C4C77 Q52922129-BC7C84FE-F553-4D35-B176-C02B07A694ED Q55280499-4D27DCFB-DAAB-4373-A5E5-1B21F2A9F1F1

P2860

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201

http://www.wikidata.org/entity/Q34268509

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Improved survival after transp ...... afts: results from BMTCTN 0201

@ast

Improved survival after transp ...... afts: results from BMTCTN 0201

@en

Improved survival after transp ...... afts: results from BMTCTN 0201

@nl

type

label

Improved survival after transp ...... afts: results from BMTCTN 0201

@ast

Improved survival after transp ...... afts: results from BMTCTN 0201

@en

Improved survival after transp ...... afts: results from BMTCTN 0201

@nl

prefLabel

Improved survival after transp ...... afts: results from BMTCTN 0201

@ast

Improved survival after transp ...... afts: results from BMTCTN 0201

@en

Improved survival after transp ...... afts: results from BMTCTN 0201

@nl

P1433

Q34268509-2EF50712-43A6-4D57-ADEE-3F8E9A992C4D

P1476

Q34268509-068B4867-7B75-48C8-B218-476C781818F8

P2093

Q34268509-30221E2A-0A1B-4CF4-A40A-7D427121900D

Q34268509-47D6200A-7DEC-4E05-A06B-531FB0BA45D8

Q34268509-6EF52253-4B85-4BA1-A610-9861FC6BF2B1

Q34268509-71F89878-846B-47B9-94FA-2F3735833B19

Q34268509-9D1B5741-14DC-4155-B132-4E3F7AF76258

Q34268509-A0CCCD39-8C1A-42A9-B48A-F05E81A4329E

Q34268509-A458E6D2-DAF1-4E98-8E2A-8863B821087B

Q34268509-A4CCF3E3-5EA9-4AEA-8AFB-8E0A5E779146

Q34268509-B9A25430-0E8C-4028-B50A-81ED4E0A4F9C

Q34268509-BC23D9F5-14D4-4350-9BC6-300C6B1BB1F1

P2860

Q34268509-068593F3-75AC-45B1-83C3-0971A8E64AC7

Q34268509-085C4A7D-871C-4FC9-8E6D-A2A6758DE746

Q34268509-0E9ADF38-6806-47C9-8CEA-B810EAB160C9

Q34268509-2B7011F5-86F7-4775-BEAF-46C6B683A9A8

Q34268509-40704C6C-D4FC-453C-A064-18894EAB7DD5

Q34268509-4AB356FD-EA05-40FA-B970-01F4FF303FE1

Q34268509-4BB49F5A-50C5-49E3-9F37-DDAF42906980

Q34268509-4E27007B-D32B-4E04-AD47-EB43A133437F

Q34268509-72BD5F25-A6AC-4E1F-8F47-CF35BFD6652C

Q34268509-78677F8D-56F5-4896-B1CD-CF1DEA06668C

P304

Q34268509-96A21BBF-15F1-417B-9613-1D22500AE1E2

P31

Q34268509-10E56EC8-403E-4BC3-A023-7E592CFEE91E

P356

Q34268509-AAF5A13F-0800-44E6-A03A-0BB47F4F48C9

P407

Q34268509-05877EBE-CC58-4BD9-88FB-FAA2269AA060

P433

Q34268509-487FA1A3-D64C-41B9-8656-AFEF6B548D44

P478

Q34268509-8EAC693E-1831-42D6-8099-86F6AF4F10AF

P577

Q34268509-67AE4333-67D2-4FC4-A1E2-1412BC475401

P698

Q34268509-CA5590CC-C590-42B2-90A6-E32F5C5E005A

P932

Q34268509-FC287DA7-F123-4CB1-8F0F-B86771E646F0

P356

JCO.2013.54.4577

P1433

Journal of Clinical Oncology

P1476

Improved survival after transp ...... afts: results from BMTCTN 0201

@en

P2093

Alan Howard

http://www.w3.org/2001/XMLSchema#string

Ann Woolfrey

http://www.w3.org/2001/XMLSchema#string

Brent R Logan

http://www.w3.org/2001/XMLSchema#string

Claudio Anasetti

http://www.w3.org/2001/XMLSchema#string

Corina E Gonzalez

http://www.w3.org/2001/XMLSchema#string

David L Porter

http://www.w3.org/2001/XMLSchema#string

Dennis L Confer

http://www.w3.org/2001/XMLSchema#string

Edmund K Waller

http://www.w3.org/2001/XMLSchema#string

John M McCarty

http://www.w3.org/2001/XMLSchema#string

Juan Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Of mice and not men: differences between mouse and human immunology

Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality

Genomic responses in mouse models poorly mimic human inflammatory diseases

CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease.

Tolerogenic dendritic cells: cytokine modulation comes of age.

The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation.

Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice.

IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.

CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine

Reconstructing immunity after allogeneic transplantation.

P304

2365-2372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2013.54.4577

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24982459

http://www.w3.org/2001/XMLSchema#string

P932

4180368

http://www.w3.org/2001/XMLSchema#string